SC Filed 2018-01-09 Event — SEC 0001535610-18-000050 →

SABBY MANAGEMENT, LLC → SenesTech, Inc. SNES

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 11/100

Passive Schedule 13G filer baseline
Short interest building (+14.3% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

7 transactions

7 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

66 filings by this filer

65 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

31,293 shares short · +14.3% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-10-22	GLENBROOK CAPITAL MANAGEMENT	10%+ owner	Buy	7,500	$0.80	$6K
2026-10-21	GLENBROOK CAPITAL MANAGEMENT	10%+ owner	Buy	60,000	$0.74	$44K
2026-10-20	GLENBROOK CAPITAL MANAGEMENT	10%+ owner	Buy	36,375	$0.67	$25K
2026-06-29	GLENBROOK CAPITAL MANAGEMENT	10%+ owner	Buy	5,172	$1.52	$8K
2026-06-26	GLENBROOK CAPITAL MANAGEMENT	10%+ owner	Buy	6,812	$1.56	$11K
2026-06-25	GLENBROOK CAPITAL MANAGEMENT	10%+ owner	Buy	9,442	$1.53	$14K
2026-06-24	GLENBROOK CAPITAL MANAGEMENT	10%+ owner	Buy	3,990	$1.55	$6K

Other 13D/G Filings on SenesTech, Inc.

Filed	Form	Filer	Stake	Shares
2026-10-26	SCHEDULE 13D	LeBeau Justin Michael	5.40%	294,773	view →
2026-10-22	SCHEDULE 13D/A	GLENBROOK CAPITAL MANAGEMENT	39.95%	2,166,973	view →
2026-10-19	SCHEDULE 13D/A	GLENBROOK CAPITAL MANAGEMENT	38.04%	2,063,098	view →
2026-07-23	SCHEDULE 13D	GLENBROOK CAPITAL MANAGEMENT	—	1,057,804	view →

Other Filings by SABBY MANAGEMENT, LLC

Filed	Form	Issuer	Stake	Shares
2024-01-02	SC	Bone Biologics Corp BBLGW	—	—	view →
2024-01-02	SC	Cocrystal Pharma, Inc. COCP	—	—	view →
2024-01-02	SC	AVENUE THERAPEUTICS, INC. ATXI	—	—	view →
2024-01-02	SC	Neptune Wellness Solutions Inc.	—	—	view →
2024-01-02	SC	RedHill Biopharma Ltd. RDHL	—	—	view →
2024-01-02	SC	Toughbuilt Industries, Inc	—	—	view →
2024-01-02	SC	Scinai Immunotherapeutics Ltd. SCNI	—	—	view →
2024-01-02	SC	Onconetix, Inc. ONCO	—	—	view →
2024-01-02	SC	Aditxt, Inc. ADTX	—	—	view →
2024-01-02	SC	Kiromic Biopharma, Inc.	—	—	view →
2024-01-02	SC	Virpax Pharmaceuticals, Inc.	—	—	view →
2024-01-02	SC	Huadi International Group Co., Ltd. HUDI	—	—	view →
2024-01-02	SC	Dogness (International) Corp DOGZ	—	—	view →
2024-01-02	SC	Pulmatrix, Inc. PULM	—	—	view →
2024-01-02	SC	Nisun International Enterprise Development Group Co., Ltd AIOS	—	—	view →
2018-01-09	SC	Axsome Therapeutics, Inc. AXSM	—	—	view →
2018-01-09	SC	CorMedix Inc. CRMD	—	—	view →
2018-01-09	SC	Onconova Therapeutics, Inc. TRAW	—	—	view →
2018-01-09	SC	BIOCEPT INC	—	—	view →
2018-01-09	SC	Trovagene, Inc. CRDF	—	—	view →

Showing 20 of 65

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →